arrow
N

Naomi B. Klarenbeek

Centre for Human Drug Research
H指数:18
被引数:1,306

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early development of LRX712, preclinical chondroanabolic findings and results from a randomized first-in-human study

LRX712的早期开发、非临床软骨再生发现及来自一项随机首次人体研究的成果

2026-09-180
OAAI
IL-2 mutein-engrafted antibody MHS552 selectively expands functional regulatory T cells in nonclinical models and healthy participants

IL-2 mutein-engrafted抗体MHS552在非临床模型和健康受试者中选择性扩增功能性调节性T细胞

2026-08-120
OA
Intravaginal Delivery of Oxybutynin: An Alternative Administration Route to Improve its Pharmacokinetic and Pharmacodynamic Effects

阴道内给予奥昔布宁:改善其药代动力学和药效学效应的替代给药途径

2026-07-230
OAAI
Repeated intradermal lipopolysaccharide challenge responses in healthy volunteers: Implications for clinical pharmacology studies

在健康志愿者中重复皮内脂多糖挑战反应:对临床药理学研究的意义

2026-04-220
OAAI
Clinical Validation of Imaging Biomarkers in Mycosis Fungoides

皮肤T细胞淋巴瘤影像生物标志物的临床验证

2026-03-110
OAAI
POLB 001; a p38 MAPK inhibitor; decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised; double-blind; placebo-controlled study
2026-01-230
OAAI
Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers

突破壁垒:作为健康志愿者中血管渗漏可控诱导的体内模型,皮内脂多糖挑战的特征描述

2025-11-150
OAAI
Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience

早期临床试验中的不良免疫刺激:基于研究者临床经验的关键发现和建议

2025-09-010
OAAI
Mild psoriasis as a suitable model for proof-of-mechanism in a phase 1B setting: Results from a double-blind placebo-controlled trial with guselkumab

中重度银屑病作为机制验证的合适模型:一项关于guselkumab的双盲、安慰剂对照试验结果

2025-07-280
OAAI
Proof of Pharmacology, Safety, and Pharmacokinetics of the Novel TRPA1 Antagonist BI 1839100: A Randomized, Placebo-Controlled, Parallel Group, First-In-Human Study in Healthy Male Participants

新型TRPA1拮抗剂BI 1839100的药理学、安全性与药代动力学证据:一项在健康男性受试者中进行的随机、安慰剂对照、平行组、首次人体研究

2025-07-250
OAAI
Profiling a Neo-Antigen-Driven Immune Response in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Study of the KLH Challenge Model

在健康志愿者中分析新抗原驱动的免疫反应:KLH挑战模型的一项随机、双盲、安慰剂对照研究

2025-07-220
OAAI
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebocontrolled exploratory clinical trial
2024-02-011
OAAI